Advertisement
Most cancer drugs that enter the market in Europe have no evidence of benefit for survival or quality of life

Most Cancer Drugs Approved in Europe Show No Survival Benefit

0
Even in the postmarketing period, half of cancers have no evidence of significant survival gain
For adolescents with macromastia

Reduction Mammaplasty Linked to Improved HRQoL in Teens

0
Improvements in health-related quality of life, breast symptoms, regardless of age, BMI
Engaging in abusive supervisory behavior may be associated with short-term beneficial effects

Short-Lived Benefits for Abusive Supervisory Behavior

0
Positive indirect effect on work engagement via recovery level, which is short-lived
Physicians are delaying retirement

Reasons Physicians Are Delaying Retirement Vary

0
Many older physicians feel that they are providing a useful service, desire part-time or occasional work
More than one in five patients report having experienced a medical error

21 Percent of Americans Report Experiencing a Medical Error

0
Survey results show patients and families feel some responsibility for patient safety
Delivery characteristics of extremely preterm infants can be used to identify those with significantly lower incidence of early-onset sepsis

Delivery Characteristics Predict Early-Onset Sepsis Risk

0
Criteria for low risk include C-section, membrane rupture, absence of clinical chorioamnionitis
For patients undergoing major abdominal surgery

Health Literacy Linked to Length of Stay After Abdominal Surgery

0
No significant correlation with increased rates of 30-day ER visits or 90-day hospital readmissions
Elevated urinary levels of the proteins TIMP-2 and IGFBP7 are a potentially useful biomarker predicting moderate to severe acute kidney injury in the early postoperative period after open heart surgery

Urinary [TIMP-2]*[IGFBP7] May Predict AKI After Heart Surgery

0
Elevated levels of the two proteins can predict risk of acute kidney injury
Many basic scientists and clinical researchers support somatic genome editing in adults for prevention of serious disease but not for human enhancement; they also believe the public should be consulted before any clinical application of germline gene editing proceeds

Scientists Support Genome Editing to Prevent Disease

0
Majority of survey respondents support gene editing to treat diseases but not human enhancement
The number of centers performing robotic surgery for radical prostatectomy increased during 2010 to 2014

Increase in Number of Centers Doing Robotic Prostatectomy

0
Radical prostatectomy centers that closed from '10 to '14 more likely in areas with strong competition